Short answer
TACTILE SYSTEMS TECHNOLOGY INC (TCMD) filed its Q1 2026 10-Q quarterly report on May 4, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $75M (up 22.8% year over year) with net income of −$2M.
Q1 2026 key financials · XBRL
- Revenue
- $75M
- +22.8% YoY
- Net income
- −$2M
- +40.7% YoY
- Operating margin
- -2.0%
- Gross margin
- 76.5%
- EPS (diluted)
- −$0.08
- +38.5% YoY
Source: XBRL data from the TACTILE SYSTEMS TECHNOLOGY INC (TCMD) Q1 2026 10-Q on SEC EDGAR. USD.
TACTILE SYSTEMS TECHNOLOGY INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $75.3M, up 23% YoY from $61.3M
- Gross margin 77% vs 74% YoY; net loss $1.8M vs $3.0M
- Best product line lymphedema, $62.2M revenue, up 23%; airway clearance $13.0M, up 22%
- Cash $75.0M vs $83.6M YoY; operating cash flow $(0.3)M vs $0.4M
- Capital deployment: $6.2M LymphaTech acquisition, $1.1M share repurchases; headwinds include inflation, labor shortages, and IT investments through 2026
Risk Factors
- No newly added risk factor; company reported no material changes from the December 31, 2025 Form 10-K
- Carried-forward risks remain the principal disclosed exposures, but specific risk details were not repeated in this 10-Q
- Share repurchase authorization up to $25.0 million may reduce available capital; $23,927,840 remained authorized at March 31, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other TACTILE SYSTEMS TECHNOLOGY INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.